F, F., M, B., F, A., A, M., FL, G., J, S., . . . NS, P. (2026). Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models. Frontiers in oncology, 16, 1766563. https://doi.org/10.3389/fonc.2026.1766563
Chicago Style (17th ed.) CitationF, Fedeli, Bistika M, Ascione F, Marangelo A, Guzzi FL, Schrader J, Harris AG, and Pellegata NS. "Anti-secretory and Anti-proliferative Actions of Next-generation Dual Subtype 2 and 5 Somatostatin Receptor Ligands in Neuroendocrine Tumor Models." Frontiers in Oncology 16 (2026): 1766563. https://doi.org/10.3389/fonc.2026.1766563.
MLA (9th ed.) CitationF, Fedeli, et al. "Anti-secretory and Anti-proliferative Actions of Next-generation Dual Subtype 2 and 5 Somatostatin Receptor Ligands in Neuroendocrine Tumor Models." Frontiers in Oncology, vol. 16, 2026, p. 1766563, https://doi.org/10.3389/fonc.2026.1766563.